» Articles » PMID: 37449600

Potential Role of Polysaccharides in Glaucoma Management: Evidence from Preclinical Studies

Overview
Date 2023 Jul 14
PMID 37449600
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, the pharmacological benefits of herbal extracts have been revisited for their potential neuroprotective effects in glaucoma. The polysaccharides extracted from the fruits of Lycium barbarum L., or Lycium barbarum polysaccharides, exert their anti-aging effect through reducing oxidative stress, modulating the immune response, enhancing neuronal responses, and promoting cytoprotection. The therapeutic efficacy of Lycium barbarum polysaccharides in preserving retinal ganglion cells and their functions was demonstrated in a range of experimental models of optic neuropathies. These include the acute and chronic ocular hypertension models, the partial optic nerve transection model, and the ischemic-reperfusion injuries model. Based on these findings, Lycium barbarum polysaccharides appear to be a good candidate to be developed as a neuroprotective agent for treating multifactorial diseases. This review aims to present a comprehensive review on the latest preclinical evidence on the pre- and post-treatment benefits of Lycium barbarum polysaccharides in retinal ganglion cell neuroprotection. The possible mechanisms of Lycium barbarum polysaccharides mediating retinal ganglion cell neuroprotection will also be described. Moreover, the potential research gaps in the effective translation of Lycium barbarum polysaccharides treatment into clinical glaucoma management will be discussed.

Citing Articles

Bushen-Huoxue-Mingmu-Formula attenuates pressurization-induced retinal ganglion cell damage by reducing mitochondrial autophagy through the inhibition of the Pink1/Parkin pathway.

Wang W, Gao J, Mu Q, Zhang D, Yang F, Cheng W Medicine (Baltimore). 2025; 104(2):e41257.

PMID: 39792763 PMC: 11730644. DOI: 10.1097/MD.0000000000041257.


Perspectives of traditional herbal medicines in treating retinitis pigmentosa.

Liu S, Matsuo T, Matsuo C, Abe T, Chen J, Sun C Front Med (Lausanne). 2024; 11:1468230.

PMID: 39712182 PMC: 11660805. DOI: 10.3389/fmed.2024.1468230.


Lycium barbarum glycopeptide promotes neuroprotection in ET-1 mediated retinal ganglion cell degeneration.

Lakshmanan Y, Wong F, So K, Chan H J Transl Med. 2024; 22(1):727.

PMID: 39103918 PMC: 11302070. DOI: 10.1186/s12967-024-05526-8.


Neuroprotective and anti-inflammatory effects of eicosane on glutamate and NMDA-induced retinal ganglion cell injury.

Wu Z, Li H, Zhu Y, Xiong M, Zhong J Int J Ophthalmol. 2024; 17(4):638-645.

PMID: 38638263 PMC: 10988067. DOI: 10.18240/ijo.2024.04.05.


Bioactive Components of and Deep-Processing Fermentation Products.

Qiang X, Xia T, Geng B, Zhao M, Li X, Zheng Y Molecules. 2023; 28(24).

PMID: 38138534 PMC: 10745962. DOI: 10.3390/molecules28248044.

References
1.
Palamar M, Yilmaz Dag M, Yagci A . The effects of Valsalva manoeuvre on Ocular Response Analyzer measurements. Clin Exp Optom. 2015; 98(5):447-50. DOI: 10.1111/cxo.12303. View

2.
Mi X, Chiu K, Van G, Leung J, Lo A, Chung S . Effect of Lycium barbarum Polysaccharides on the expression of endothelin-1 and its receptors in an ocular hypertension model of rat glaucoma. Neural Regen Res. 2015; 7(9):645-51. PMC: 4347002. DOI: 10.3969/j.issn.1673-5374.2012.09.001. View

3.
Luo Q, Cai Y, Yan J, Sun M, Corke H . Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004; 76(2):137-49. DOI: 10.1016/j.lfs.2004.04.056. View

4.
Ahmed F, Brown K, Stephan D, Morrison J, Johnson E, Tomarev S . Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci. 2004; 45(4):1247-58. DOI: 10.1167/iovs.03-1123. View

5.
Leung C, Weinreb R, Wei Li Z, Liu S, Lindsey J, Choi N . Long-term in vivo imaging and measurement of dendritic shrinkage of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2011; 52(3):1539-47. DOI: 10.1167/iovs.10-6012. View